Buy the Carmat Share on the Stock Exchange in 2026?

Discover the essential information to know beforeBuy Carmat shares for an investment under the best possible conditions. Carmat is a biomedical company specializing in the design and total manufacturing of artificial hearts. The company is listed on Euronext Paris under the stock symbol ALCAR.

How to buy Carmat shares on the stock market?

1. Go to the site of a reliable and ideal broker to buy Carmat shares.
2. Complete the online registration form to create your investment account.
3. Make a first capital deposit into your trading account to fund it.
4. Look for the Carmat security on the platform and place your first purchase order.

Quotation and Carmat Share Price in Real Time

Best Stock Broker to Buy Carmat Stock

Is this the right time to buy Carmat shares? - Notice

Indeed, the moment is favorable because Carmat is launching a capital increase with a cancellation of shareholder subscription privileges with a priority period of 5 trading days for irreducible shareholders.

• Price increase: Its price has increased from 12 euros to 28 euros since March 2020
• Point for investors: The support level between 20 and 22 euros is a good entry point for the most cautious investors.
• Goal, annual record: In case of good news, the objective of 33 euros will be easily reached.

Yield Buy Carmat Share

The Carmat group does not currently pay a dividend to its shareholders. Find out why on the page Carmat dividend.

Carmat Action – Buy or Sell in 2026?

1. Revolutionary Activity: The Aeson® complete cardiac bioprosthesis can contribute to the revolution of medicine.
2. Successful Project: Marketing in Europe and obtaining CE marking
3. Company financed by several entities

Therefore, at present, the percentage of analysts who agree on the Carmat share indicates a strong buy recommendation.

Market Capitalization and Key Figures Carmat Share

When to Buy Carmat Stock

In order to know the perfect time to buy Carmat shares, you must first know your investment horizon and your method. Moreover, given this rise in Carmat shares, the consensus suggests that you should favor buying in September 2025.

Why Invest in the Carmat Share?

• Activity that helps and revolutionizes – The Aeson artificial heart performs the same functions as the human heart
• Growing sector
• The project is granted by the FDA – for clinical trials in the USA
• Supported Company
• Strong resilience

Buy Action Carmat – Benefit from the business of Health Technology

Carmat being a creator and promoter of the most innovative total artificial heart project in the world, intended to satisfy an unmet medical need by offering a therapeutic alternative to patients suffering from end-stage bi-ventricular heart failure. The medical sector is undoubtedly a promising activity.

This sector being very fashionable at the moment, discover the best shares of Biotech (Buy Biotech Stock).

Should I Sell or Buy the Carmat Share?

If you are wondering whether to buy or sell Carmat stock right now. The ideal to make a potential upside or downside of its course.

• If the course is inferior, we recommendthe purchase.
• If the course is higher, we advise to sell or stay away

Like the favorite adage of investors: “the stock market is about the long term”. Consequently, it is crucial to take into account all the dividends that CARMAT will pay in order to assess its overall performance.

With Which Stock Exchange Products Should I Buy Carmat Shares?

• Buy Carmat shares with a PEA or securities account with the broker DEGIRO
• Trading on Carmat shares with a PEA-PME: Always with DEGIRO
• Indeed, you can buy the Carmat share with the stock market products mentioned above.

Carmat Share Price Forecast

Carmat Share Price Analysis

• Fundamental Analysis of the Carmat Share
• Technical Analysis of the Carmat Share
• Factors Influencing the Carmat Share Price

Fundamental Analysis of the Carmat Share

• Project expansion: More and more implants are being performed in patients
• Capital increase with the elimination of shareholders' preferential subscription rights.
• Analyses differ: Each analyst has their own point of view on this – so it's still a bit difficult to assess
• No dividends: Carmat does not pay dividends to its shareholders

Technical Analysis of the Carmat Share

• Positive MACD: Returns the sell signal
• Positive RSI: confirms the good orientation towards this action
• Stochastic Indicators: indicates buy signals
• Moving averages: A strong buy signal

To conclude, the technical analyzes of the carmat share show buy signals for this security.

Factors Influencing the Carmat Share Price

• Regulatory factors in the health sector: the price suddenly took 50% while obtaining its European Certification (CE)
• Technological advances

Buy the Carmat Share or the Abiomed Share?

Carmat Action: What Future?

The Carmat company has a bright future ahead of it. The variations of the ALCAR price are very satisfactory these days and the analysts are very positive. The success of clinical trials could be the source of the rise in stock prices. For this, these experts believe that the price of this action will rise further during the months and years that follow.

The Carmat Business Model

This part focuses on the main points of Carmat's Business Model. The different points studied are:

• Heart Health: The artificial heart is intended for patients with end-stage biventricular heart failure.
• Save on the cost of immunosuppressant treatments

Turnover, Income from the Carmat Share

Carmat recently published its financial results for 2020. It reports a turnover of 230 million euros with a negative net result of -41,7 million euros. Carmat's income stream depends on the following activities:

• Production
• The commercialization of artificial hearts

Who are the Carmat Partners?

• OSSEOUS
• Pack'Aero
• Health
• Iris
• Vignal Artru Industries

Who are Carmat's Competitors?

• Abiomed
• Syncardia
• bivacor

History and background of the Carmat company

• 2008: Creation of the Carmat company, a combination of Carpentier and Matra
• 2010: Year of introduction of Carmat on the Alternext market in the Paris stock exchange
• 2013: Obtaining ANSM authorization and success of the first implantation
• 2016: Initiation of work related to the pivotal study
• 2017: Application for CE marking
• 2020: Obtaining FDA approval and obtaining CE marking
• 2025: Realization of the first implantation of the Aeson cardiac bioprosthesis in a human

Stock market investment at Carmat – A promising stock market investment?

In our opinion Buy shares in 2026 is ideal because it is not only the best option but also has many advantages.vantages. Throughout this review, you have been able to see the avantages and the limits of this stock market asset. Having had historic emergences recently, the ALCAR stock price will rise. In short, to anticipate this potential future success, we still advise you to buy Carmat shares in 2025 via a renowned platform.

❓How much to invest in a Carmat Share?

The amount to invest in a Carmat share essentially depends on your budget. In any case, invest only the money that you can afford to lose. Also, consider diversifying your portfolio to avoid losing everything in case of problems.

When to invest in Carmat shares?

The consensus of analysts says that it would be interesting to invest in a Carmat share now. However, we recommend that you perform a full instrument scan before committing.

Carmat Action: Buy or Trade?

The purchase is recommended for cautious investors who wish to make capital gains over the long term. Trading, which consists of betting on the evolution of the price of the asset without holding it, is intended for people who wish to profit from price fluctuations in the short term. This practice is risky and we only recommend it to experienced traders.